Bellidifolin

Bellidifolin is an orally active anti-inflammatory agent that demonstrates antiproliferative and antioxidant properties. It modulates crucial signaling pathways, including STAT3, PI3K-Akt, mTOR, and BRD4, while inhibiting the viral protein R (Vpr). Bellidifolin induces cell cycle arrest and apoptosis, exhibits significant antifibrotic effects, and offers protective benefits to the heart, liver, and nervous system. This compound is valuable for research into diseases such as lung cancer, non-alcoholic fatty liver disease, myocardial hypertrophy, and ischemic cranial nerve injury.